All charts and data below are with dividends reinvested. (Inflation adjustment is OFF !)
| Mon 1984-11-05? to Fri 2024-12-20 |
YTD
Return |
TR
Price |
||||
|---|---|---|---|---|---|---|
| GSK × |
−5.76%
2024-12-20 |
45.98 TR
2024-12-20 |
||||
| GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
| Mon 1984-11-05? to Fri 2024-12-20 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| GSK × |
+4,498.33%
+10.01%/yr |
+7.93%/yr
(R2=0.811) |
||||
| GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
| Mon 1984-11-05? to Fri 2024-12-20 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| GSK × |
$10,000.00
1984-11-05 |
$459,833.04
2024-12-20 |
||||
| GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
| Year | GSK |
|---|---|
| 2024 (YTD) | −5.76% |
| 2023 | +9.71% |
| 2022 | −18.27% |
| 2021 | +26.63% |
| 2020 | −17.78% |
| 2019 | +29.12% |
| 2018 | +13.68% |
| 2017 | −3.07% |
| 2016 | +1.97% |
| 2015 | −0.36% |
| 2014 | −15.76% |
| 2013 | +28.81% |
| 2012 | +0.55% |
| 2011 | +22.49% |
| 2010 | −2.21% |
| 2009 | +19.23% |
| 2008 | −22.33% |
| 2007 | −0.84% |
| 2006 | +7.88% |
| 2005 | +9.81% |
| 2004 | +5.54% |
| 2003 | +28.67% |
| 2002 | −21.65% |
| 2001 | −9.66% |
| 2000 | +4.09% |
| 1999 | −17.96% |
| 1998 | +48.13% |
| 1997 | +55.76% |
| 1996 | +17.83% |
| 1995 | +45.17% |
| 1994 | +2.98% |
| 1993 | −10.46% |
| 1992 | −22.95% |
| 1991 | +98.85% |
| 1990 | +30.37% |
| 1989 | +38.65% |
| 1988 | +6.96% |
| 1987 | +20.45% |
| 1986 | +39.16% |
| 1985 | +74.87% |
| 1984 | −1.93% |
| Mon 1984-11-05? to Fri 2024-12-20 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| GSK × | −25.07% |
−55.21%
1993-08-13 |
||||
| GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||